Breaking

Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz Xbox Reportedly Closing Ninja Theory Studio Updated COVID-19 Vaccines Show Significant Cardiovascular Protection, Study Finds Meta's New AI Mode on Facebook Will Use Public Posts for Search Results Cuban-American Remittance Platform Envioscuba.com Ceases Operations Amid US Sanctions Fox Acquires Roku in $22 Billion Deal, Raising Concerns Over Media Consolidation Chinese Rocket Upper Stage Breaks Apart in Orbit, Spreading Debris Nvidia Plans $25 Billion Debt Sale Amid AI Boom AMD Quietly Removes TSME Security Feature from Consumer CPUs US Government Orders AI Firm Anthropic to Block Foreign Nationals from Accessing New Models Trump and Iran Reach Initial Agreement to End War, Reopen Strait of Hormuz Xbox Reportedly Closing Ninja Theory Studio Updated COVID-19 Vaccines Show Significant Cardiovascular Protection, Study Finds Meta's New AI Mode on Facebook Will Use Public Posts for Search Results Cuban-American Remittance Platform Envioscuba.com Ceases Operations Amid US Sanctions Fox Acquires Roku in $22 Billion Deal, Raising Concerns Over Media Consolidation Chinese Rocket Upper Stage Breaks Apart in Orbit, Spreading Debris Nvidia Plans $25 Billion Debt Sale Amid AI Boom AMD Quietly Removes TSME Security Feature from Consumer CPUs US Government Orders AI Firm Anthropic to Block Foreign Nationals from Accessing New Models

market competition

Steady2 stories2 sourcesLast updated: 4/22/2026

Related Topicsvolume-based procurement multinational companies biotech pharmaceuticals healthcare policy China private healthcare drug pricing

Latest Stories

China's Volume-Based Procurement Reshapes Pharmaceutical Market Dynamics

4/22/2026AI summary

China's Volume-Based Procurement Reshapes Pharmaceutical Market Dynamics

China's volume-based procurement policy, which mandates bulk drug purchases for public hospitals, is intensifying price competition for multinational pharmaceutical companies while creating more profitable channels for domestic biotech firms in the private market. Analysts note potential benefits for internet healthcare platforms, pharmacies, and private hospital services.

China's Volume-Based Drug Procurement Policy Creates Two-Tier Market

Business·4/22/2026AI summary

China's Volume-Based Drug Procurement Policy Creates Two-Tier Market

China's volume-based procurement policy forces multinational drug companies to lower prices for public hospital purchases while allowing biotech firms to charge premium prices in the private market. The dual-track system benefits internet healthcare platforms and private healthcare providers like Alibaba Health, Yifeng and Hygeia, according to Citi research.